Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

vinorelbine tartrate

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

Tubulin polymerization inhibitor

Related drugs:

No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Nasopharyngeal Carcinoma	No biomarker	Nasopharyngeal Carcinoma	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Sarcoma	No biomarker	Sarcoma	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2	gemcitabine + vinorelbine tartrate Sensitive: A2 - Guideline gemcitabine + vinorelbine tartrate Sensitive : A2
No biomarker	Small Cell Lung Cancer	No biomarker	Small Cell Lung Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Salivary Gland Cancer	No biomarker	Salivary Gland Cancer	cisplatin + vinorelbine tartrate Sensitive: A2 - Guideline cisplatin + vinorelbine tartrate Sensitive : A2	cisplatin + vinorelbine tartrate Sensitive: A2 - Guideline cisplatin + vinorelbine tartrate Sensitive : A2
HER-2 negative	HER2 Negative Breast Cancer	HER-2 negative	HER2 Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
BRCA2 mutation	Triple Negative Breast Cancer	BRCA2 mutation	Triple Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
BRCA1 mutation	Triple Negative Breast Cancer	BRCA1 mutation	Triple Negative Breast Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2	vinorelbine tartrate Sensitive: A2 - Guideline vinorelbine tartrate Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	cyclophosphamide + vinorelbine tartrate Sensitive: A2 - Guideline cyclophosphamide + vinorelbine tartrate Sensitive : A2	cyclophosphamide + vinorelbine tartrate Sensitive: A2 - Guideline cyclophosphamide + vinorelbine tartrate Sensitive : A2